Updated:
ConcertAI
ConcertAI orchestrates clinical expertise, real-world data, and applied AI to deliver practical intelligence for the demands of oncology and other complex...
ConcertAI
ConcertAI orchestrates clinical expertise, real-world data, and applied AI to deliver practical intelligence for the demands of oncology and other complex diseases.
General information
Firm type
Asset Manager
Location
Region
North America
Country
United States
City
Cambridge
Corporate office
Cambridge, MA, United States
Additional offices
Durham, NC · Frankfurt, Germany · Tokyo, Japan
Sector focus
Frequently asked questions
What is the relationship between ConcertAI and TeraRecon?
TeraRecon operates as a ConcertAI subsidiary, providing FDA-cleared advanced visualization and AI-driven imaging software. It maintains its own headquarters in Durham, North Carolina, and international offices in Frankfurt and Tokyo, functioning as the imaging-software arm of ConcertAI's broader oncology data platform.
Which therapeutic areas does ConcertAI cover, and are there notable exclusions?
Public materials commit the firm to oncology and other complex diseases. Oncology remains the most visibly developed vertical, supported by real-world data assets and investigator-site tools. No explicit sector avoidances are published, though the commercial focus stays tightly coupled to cancer-research workflows.
How does ConcertAI generate revenue?
ConcertAI licenses real-world data, AI models, and workflow software to pharmaceutical sponsors and clinical research organizations. Its TeraRecon subsidiary sells imaging-software subscriptions and associated support services, creating a dual revenue architecture from data plus regulated medical-device software.
Is ConcertAI structured as a single family office or an institutional investor?
ConcertAI presents as an operating company rather than a single-family office or fund manager. Public filings and the firm's own website provide no indication of pooled investment vehicles, fund commitments, or family-office governance — it operates as a commercial health-AI business serving external enterprise clients.
What is ConcertAI's known posture on international data compliance?
The TeraRecon subsidiary lists a Data Privacy Framework Policy on its website footer, consistent with transatlantic data-transfer requirements. ConcertAI's broader platform-specific compliance certifications are not publicly detailed; regulatory posture is inferred from the subsidiary's published policies rather than a consolidated corporate disclosure.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on asset managers?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: